Protocol for kinetic mode potassium channel assays on common plate readers and microscopes.


Journal

SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 09 11 2023
revised: 02 02 2024
accepted: 01 03 2024
medline: 28 4 2024
pubmed: 28 4 2024
entrez: 27 4 2024
Statut: ppublish

Résumé

Fluorescence-based potassium channel assays are typically run on expensive, hard to obtain, fluorescence imaging kinetic plate readers that are uncommon in most laboratories. Here we describe the use of the Brilliant Thallium Snapshot assay to conduct an endpoint potassium channel assay, so that it can be used across multiple plate reader platforms that are more common in many labs. These methods will allow users to identify modulators of potassium channels. For this work, we have taken a kinetic mode Molecular Devices FLIPR based protocol and adapted it to be utilized on endpoint plate readers, such as the BMG Labtech PHERAstar, to identify activators of GIRK channels in CHO cells. We demonstrate that both plate readers are functionally competent at generating excellent Z' values which makes them ideally suited to finding corollary hits from the Sigma LOPAC 1,280 screening collection. Importantly, this assay has also been validated using a high content reader, demonstrating the possibility of spatially resolving signals from individual cells within a mixed cell population. The compendium of these results shows the flexibility, accessibility and functionality of endpoint-compatible potassium channel assay readouts on more common plate readers.

Identifiants

pubmed: 38677875
pii: S2472-5552(24)00010-8
doi: 10.1016/j.slasd.2024.100148
pii:
doi:

Substances chimiques

Potassium Channels 0
G Protein-Coupled Inwardly-Rectifying Potassium Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100148

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest LD, PP and AR were employees of Cerevance Ltd at the time of their contribution to this work. The remaining authors declared no potential conflict of interest with respect to the research, authorship and or publication of this article.

Auteurs

Emery Smith (E)

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, 130 Scripps Way #1A1, Jupiter, FL 33458, United States.

Louise Dickson (L)

Cerevance Ltd., 418 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0PZ, United Kingdom.

Philip Pickford (P)

Cerevance Ltd., 418 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0PZ, United Kingdom.

Anna Rowland (A)

Cerevance Ltd., 418 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0PZ, United Kingdom.

Justin Shumate (J)

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, 130 Scripps Way #1A1, Jupiter, FL 33458, United States.

Katherine Perez (K)

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, 130 Scripps Way #1A1, Jupiter, FL 33458, United States.

Louis Scampavia (L)

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, 130 Scripps Way #1A1, Jupiter, FL 33458, United States.

Derek Hernandez (D)

Ion Biosciences, San Marcos, TX 78666, United States.

Timothy P Spicer (TP)

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, 130 Scripps Way #1A1, Jupiter, FL 33458, United States. Electronic address: spicert@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH